Juodkalnija -
kroatų -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
ezrusta 10mg + 10mg film tableta
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - rosuvastatin, ezetimib - film tableta - 10mg + 10mg
Juodkalnija -
kroatų -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
ezrusta 20mg + 10mg film tableta
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - rosuvastatin, ezetimib - film tableta - 20mg + 10mg
Juodkalnija -
kroatų -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
vigamox 5mg/ml kapi za oči, rastvor
"novartis pharma services ag" dio stranog druŠtva podgorica - moksifloksacin - kapi za oči, rastvor - 5mg/ml
Juodkalnija -
kroatų -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
azopt 10mg/ml kapi za oči, suspenzija
"novartis pharma services ag" dio stranog druŠtva podgorica - brinzolamid - kapi za oči, suspenzija - 10mg/ml
Juodkalnija -
kroatų -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
travatan 40 mikrograma/ml kapi za oči, rastvor
"novartis pharma services ag" dio stranog druŠtva podgorica - travoprost - kapi za oči, rastvor - 40 mikrograma/ml
Juodkalnija -
kroatų -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
duotrav 5mg/ml + 40 mikrograma/ml kapi za oči, rastvor
"novartis pharma services ag" dio stranog druŠtva podgorica - timolol, travoprost - kapi za oči, rastvor - 5mg/ml + 40 mikrograma/ml
Europos Sąjunga -
kroatų -
EMA (European Medicines Agency)
elmiron
bene-arzneimittel gmbh - pentosan polisulfat natrij - cistitis, međuprostorni - urologicals - elmiron je indiciran za liječenje sindroma boli mokraćnog mjehura koji su karakterizirani glomerulacijama ili hunnerovim lezijama kod odraslih osoba s umjerenom ili jakom boli, hitnošću i učestalošću mokrenja.
Europos Sąjunga -
kroatų -
EMA (European Medicines Agency)
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Иммуностимуляторы, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
